XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:        
Net product sales $ 31,762 $ 27,630 $ 61,377 $ 51,087
Operating expenses:        
Cost of product sales 20,158 16,175 37,012 27,530
Research and development 17,572 28,834 31,389 70,904
General and administrative 15,230 9,181 26,083 18,714
Sales and marketing 21,205 22,938 42,359 46,360
Total operating expenses 74,165 77,128 136,843 163,508
Loss from operations (42,403) (49,498) (75,466) (112,421)
Other income (expense), net 344 (6,861) 639 (7,826)
Net loss (42,059) (56,359) (74,827) (120,247)
Other comprehensive income (loss):        
Unrealized gains (losses) on short-term investments (15) (3) 13 (5)
Comprehensive loss $ (42,074) $ (56,362) $ (74,814) $ (120,252)
Basic net loss per share $ (0.35) $ (0.55) $ (0.63) $ (1.18)
Weighted average common shares outstanding, basic 119,719 102,405 119,484 102,265
Diluted net loss per share $ (0.35) $ (0.55) $ (0.63) $ (1.18)
Weighted average common shares outstanding, diluted 119,719 102,405 119,484 102,265